Clinical Trial Update: Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy, safety, withdrawal, and retreatment with brodalumab in moderate to severe plaque psoriasis; study terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 3 | Status: TERMINATED | Results posted: 2020-01-03